Vor Biopharma, announced the appointment of John King as chief commercial officer. Mr. King has more than 20 years of global commercial leadership experience within biotechnology and rare diseases. Mr. King will plan and lead global commercial operations as Vor continues to advance its lead programme VOR33 and future programmes that leverage its technology platform for the treatment of cancer.